Aspen Neuroscience
- Biotech or pharma, therapeutic R&D
Aspen Neuroscience, Inc. is a clinical-stage, private company focused on autologous regenerative medicines, beginning with autologous neuron replacement for Parkinson’s disease in a Phase 1/2a open label clinical trial. Aspen has successfully completed dosing of the first two cohorts of patients - demonstration of early safety and efficacy.
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}